logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Agnese Losurdo

IRCCS Humanitas Research Hospital
H指数:20
被引数:1,521

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience

手术后接受vorasidenib的CNS 3级IDH突变型胶质瘤患者的驾驶选择和临床过程的原因: 试点经验

Journal of Neuro-Oncology
IF3.1
2026-01-280
PRE
Angelo Dipasquale; Pasqualina Giordano; Alberto Bosio; Maarten M. J. Wijnenga; Laura Giordano; Agnese Losurdo; Pasquale Persico; Marta Padovan; Angela Viggiano; Giuseppe Catapano; Marjolein Geurts; Federico Pessina; Armando Santoro; Giuseppe Lombardi; Matteo Simonelli
A PHASE 1, FIRST-IN-HUMAN STUDY OF REGORAFENIB PLUS TEMOZOLOMIDE WITH OR WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED MGMT METHYLATED, IDH WILDTYPE GLIOBLASTOMA: THE REGOMA-2 TRIAL

一项关于瑞戈非尼联合替莫唑胺，在有或无放疗情况下，用于新诊断的MGMT甲基化、IDH野生型胶质母细胞瘤患者的I期首个人类研究：REGOMA-2试验

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Padovan, Marta; Simonelli, Matteo; De Nicolo, Amedeo; Bianco, Paola Del; Cerretti, Giulia; Caccese, Mario; Persico, Pasquale; Menegatti, Giorgia; Bosio, Alberto; Dipasquale, Angelo; Maccari, Marta; Losurdo, Agnese; Coppola, Marina; Krengli, Marco; Lonardi, Sara; D'Avolio, Antonio; De Salvo, Gian Luca; Lombardi, Giuseppe
A PHASE 1, FIRST-IN-HUMAN STUDY OF REGORAFENIB PLUS TEMOZOLOMIDE WITH OR WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED MGMT METHYLATED, IDH WILDTYPE GLIOBLASTOMA: REGOMA-2 TRIAL

一项关于瑞戈非尼联合替莫唑胺，无论是否联用放疗，在 newly diagnosed MGMT methylated, IDH wildtype glioblastoma 患者中的首次人体研究的第1阶段：REGOMA-2试验

NEURO-ONCOLOGY
IF13.4
2025-10-010
OAAI
Padovan, M.; Simonelli, M.; De Nicolo, A.; Del Bianco, P.; Cerretti, G.; Caccese, M.; Persico, P.; Menegatti, G.; Bosio, A.; Dipasquale, A.; Maccari, M.; Losurdo, A.; Coppola, M.; Krengli, M.; Lonardi, S.; D'Avolio, A.; De Salvo, G.; Lombardi, G.
Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity

淋巴结来源的干细胞样但不是肿瘤组织驻留的CD8 T细胞燃料抗癌免疫

Nature Immunology
IF27.6
2025-07-290
PRE
Sharanya K. M. Wijesinghe; Lisa Rausch; Sarah S. Gabriel; Giovanni Galletti; Marco De Luca; Lei Qin; Lifen Wen; Carlson Tsui; Kevin Man; Leonie Heyden; Teisha Mason; Lewis D. Newland; Andrew Kueh; Yang Liao; David Chisanga; Julian Swatler; Emanuele Voulaz; Giuseppe Marulli; Valentina Errico; Agnese Losurdo; Gustavo R. Rossi; Fernando Souza-Fonseca-Guimaraes; Nicholas D. Huntington; Thomas Gebhardt; Daniel T. Utzschneider; Marco J. Herold; Wei Shi; Jan Schroeder; Enrico Lugli; Axel Kallies
Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events

免疫检查点抑制剂治疗患者中心脏不良事件的MRI研究：一项前瞻性队列研究

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2025-03-180
OA
Losurdo, Agnese; Panico, Cristina; Catalano, Chiara; Serio, Simone; Giordano, Laura; Monti, Lorenzo; Catapano, Federica; Figliozzi, Stefano; D'Andrea, Carla; Dipasquale, Angelo; Persico, Pasquale; Di Muzio, Antonio; Cremonesi, Marco; Marchese, Alessandro; Tronconi, Maria Chiara; Perrino, Matteo; Finocchiaro, Giovanna; Lugli, Enrico; Condorelli, Gianluigi; Simonelli, Matteo; Kallikourdis, Marinos
NaCl enhances CD8+ T cell effector functions in cancer immunotherapy
NATURE IMMUNOLOGY
IF27.6
2024-08-282
PRE
Scirgolea, Caterina; Sottile, Rosa; De Luca, Marco; Susana, Alberto; Carnevale, Silvia; Puccio, Simone; Ferrari, Valentina; Lise, Veronica; Contarini, Giorgia; Scarpa, Alice; Scamardella, Eloise; Feno, Simona; Camisaschi, Chiara; De Simone, Gabriele; Basso, Gianluca; Giuliano, Desiree; Mazza, Emilia Maria Cristina; Gattinoni, Luca; Roychoudhuri, Rahul; Voulaz, Emanuele; Di Mitri, Diletta; Simonelli, Matteo; Losurdo, Agnese; Pozzi, Davide; Tsui, Carlson; Kallies, Axel; Timo, Sara; Martano, Giuseppe; Barberis, Elettra; Manfredi, Marcello; Rescigno, Maria; Jaillon, Sebastien; Lugli, Enrico
Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram

使用新颖且外部验证的预后列线图，为下一代免疫治疗早期临床试验优化患者选择

FRONTIERS IN IMMUNOLOGY
IF5.9
2024-01-150
OAAI
Losurdo, Agnese; Dipasquale, Angelo; Giordano, Laura; Persico, Pasquale; Lorenzi, Elena; Di Muzio, Antonio; Barigazzi, Chiara; Korolewicz, James; Mehan, Aman; Mohammed, Oreoluwa; Scheiner, Benhard; Pinato, David J.; Santoro, Armando; Simonelli, Matteo
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors

外周血淋巴细胞预测接受CDK4/6抑制剂治疗的激素受体阳性HER2-negative晚期乳腺癌患者的临床结局

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2023-12-201
OAAI
Zattarin, Emma; Mariani, Luigi; Menichetti, Alice; Leporati, Rita; Provenzano, Leonardo; Ligorio, Francesca; Fuca, Giovanni; Lobefaro, Riccardo; Lalli, Luca; Vingiani, Andrea; Nichetti, Federico; Griguolo, Gaia; Sirico, Marianna; Bernocchi, Ottavia; Marra, Antonio; Corti, Chiara; Zagami, Paola; Agostinetto, Elisa; Jacobs, Flavia; Di Mauro, Pierluigi; Presti, Daniele; Sposetti, Caterina; Giorgi, Carlo Alberto; Guarneri, Valentina; Pedersini, Rebecca; Losurdo, Agnese; Generali, Daniele; Curigliano, Giuseppe; Pruneri, Giancarlo; de Braud, Filippo; Dieci, Maria Vittoria; Vernieri, Claudio
Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation

通过多组询问揭示了人类原发性和转移性脑肿瘤中T细胞的表型多样性

NATURE CANCER
IF28.5
2023-05-2219
OAAI
Wischnewski, Vladimir; Maas, Roeltje R.; Aruffo, Paola Guerrero; Soukup, Klara; Galletti, Giovanni; Kornete, Mara; Galland, Sabine; Fournier, Nadine; Lilja, Johanna; Wirapati, Pratyaksha; Lourenco, Joao; Scarpa, Alice; Daniel, Roy T.; Hottinger, Andreas F.; Brouland, Jean-Philippe; Losurdo, Agnese; Voulaz, Emanuele; Alloisio, Marco; Hegi, Monika E.; Lugli, Enrico; Joyce, Johanna A.
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors
NPJ BREAST CANCER
IF7.6
2023-04-1715
OAAI
Zattarin, Emma; Presti, Daniele; Mariani, Luigi; Sposetti, Caterina; Leporati, Rita; Menichetti, Alice; Corti, Chiara; Benvenuti, Chiara; Fuca, Giovanni; Lobefaro, Riccardo; Ligorio, Francesca; Provenzano, Leonardo; Vingiani, Andrea; Del Vecchio, Marta; Griguolo, Gaia; Sirico, Marianna; Bernocchi, Ottavia; Marra, Antonio; Zagami, Paola; Agostinetto, Elisa; Jacobs, Flavia; Di Mauro, Pierluigi; Esposito, Andrea; Giorgi, Carlo Alberto; Lalli, Luca; Boldrini, Laura; Giacchetti, Pier Paolo Berton; Schianca, Ambra Carnevale; Guarneri, Valentina; Pedersini, Rebecca; Losurdo, Agnese; Zambelli, Alberto; Generali, Daniele; Criscitiello, Carmen; Curigliano, Giuseppe; Pruneri, Giancarlo; de Braud, Filippo; Dieci, Maria Vittoria; Vernieri, Claudio
HER2-Low Status is Associated with Worse Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Patients Treated With First-Line Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy
CANCER RESEARCH
IF16.6
2023-03-013
PRE
Zattarin, Emma; Sposetti, Caterina; Leporati, Rita; Mariani, Luigi; Menichetti, Alice; Corti, Chiara; Benvenuti, Chiara; Fuca, Giovanni; Lobefaro, Riccardo; Ligorio, Francesca; Presti, Daniele; Provenzano, Leonardo; Vingiani, Andrea; Griguolo, Gaia; Sirico, Marianna; Bernocchi, Ottavia; Marra, Antonio; Zagami, Paola; Agostinetto, Elisa; Jacobs, Flavia; Di Mauro, Pierluigi; Esposito, Andrea; Giorgi, Carlo Alberto; Lalli, Luca; Boldrini, Laura; Giachetti, Pier Paolo Maria Berton; Schianca, Ambra Carnevale; Guarneri, Valentina; Pedersini, Rebecca; Losurdo, Agnese; Zambelli, Alberto; Generali, Daniele Giulio; Curigliano, Giuseppe; Pruneri, Giancarlo; de Braud, Filippo; Dieci, Maria Vittoria; Vernieri, Claudio

研究方向

暂未获取到该数据
A
Armando Santoro
H 指数:121论文数:1,855被引数:7.7万
P
Pasquale Persico
H 指数:16论文数:120被引数:945
A
Angelo Dipasquale
H 指数:15论文数:86被引数:468
R
Rosalba Torrisi
H 指数:40论文数:217被引数:5,801
M
Matteo Simonelli
H 指数:32论文数:275被引数:3,889
C
Corrado Tinterri
H 指数:27论文数:191被引数:2,682
E
Elisa Agostinetto
H 指数:25论文数:203被引数:2,725
G
Giovanna Masci
H 指数:25论文数:150被引数:2,604
L
Laura Giordano
H 指数:39论文数:417被引数:5,567
E
Enrico Lugli
H 指数:55论文数:240被引数:2.4万